Journal History
2011 | The inaugural issue is released. JPM is published as a quarterly journal. The first Special Issue “Recent Advances in Personalized Medicine” is announced. |
2013 | JPM is indexed in Scopus/SciVerse. |
2014 | JPM is indexed in PubMed and PubMed Central (PMC). |
2016 | JPM starts the Travel Awards project. |
2018 | JPM is covered by the Emerging Sources Citation Index, and receives its CiteScore™ metrics of 2.62, which equals rank 54/189 (Q1) in 'Medicine (miscellaneous)'. |
2019 | Journal of Personalized Medicine is accepted into SCIE as it is identified as a high performer, ranking in Q1. |
2020 | JPM receives its First Impact Factor of 4.433 (Journal Citation Report, 2019 Edition). JPM now ranks 10/102(Q1) in the category "Health Care Sciences & Services", 24/165(Q1) in the category "Medicine, General & Internal". |
2021 | JPM becomes a Monthly Publication. The 2020 Impact Factor is 4.945. JPM now ranks 15/108(Q1) in the category " Health Care Sciences & Services", 31/169(Q1) in the category "Medicine, General & Internal". Prof. Dr. David Alan Rizzieri accepted the role of Editor-in-Chief of JPM. |
Editor-in-Chief
2011–2015 | Founding Editor-in-Chief: Prof. Dr. Urs A. Meyer |
2015–2021 | Editor-in-Chief: Prof. Dr. Stephen B. Liggett |
2021–present | Editor-in-Chief: Prof. Dr. David Alan Rizzieri |
Section Editor-in-Chief
2021–present | Section Editor-in-Chief: Prof. Dr. Enrico Mini for the section on Pharmacogenetics Section Editor-in-Chief: Prof. Dr. Richard E. Frye for the section on Mechanisms of Diseases Section Editor-in-Chief: Prof. Dr. Kenneth P.H. Pritzker for the section on Clinical Medicine, Cell, and Organism Physiology Section Editor-in-Chief: Prof. Dr. K. Ray Chaudhuri for the section on Methodology, Drug and Device Discovery |
2022–present | Section Editor-in-Chief: Prof. Dr. Salvatore Scacco for the section on Omics/Informatics Section Editor-in-Chief: Prof. Dr. Marijn Speeckaert for the section on Epidemiology |